Mellar P Davis

30PUBLICATIONS
17CO-AUTHORS
Clinical pharmacology and therapeuticsBasic pharmacologyChemotherapyCross-sectional analysisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jan 07, 2026
Biased Kappa-opioid Agonist Strategies in Pain Management: Approaches to Clinical Benefits with Reduced Adverse Effects.

Mellar P Davis, Boris Kiselev

|Feb 17, 2025
Inpatient Use of Valproic Acid in Agitated Delirium by Palliative Medicine.

Sarah Jacobs, Leah Herbst, Carlos Fernandez

|Jan 28, 2025
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits.

Mellar Davis

|Aug 01, 2024
Novel drug treatments for pain in advanced cancer and serious illness: a focus on neuropathic pain and chemotherapy-induced peripheral neuropathy.

Mellar P Davis

|Jun 10, 2024
Novel therapies for nausea and vomiting in advanced illness and supportive cancer care.

Mellar P Davis

|Mar 07, 2024
State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: an ecological study of ARCOS and CDC WONDER data in the USA.

Jay P Solgama, Edward Liu, Mellar Davis

Pageof 5

Frequent Collaborators

6 joint publications

Carlos Fernandez Cuartas

1 joint publications

Waqas Jehangir

1 joint publications

Alexander D Karabachev

1 joint publications

Jay P Solgama